| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba7526e95eb2b534458bf1f450a8f87a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-45 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17 |
| filingDate |
2019-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13a7da9ba16acb3fcfbaf0cf0f7ab006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2919026062f2316ddcc3221251a41230
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df5b7d01ab8500446565f3119304edca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edbe40065bb0c80b9d6ee6f1fc05729c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29d734a5429c0b6b2cfeb5ef1a3ff613 |
| publicationDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020027094-A1 |
| titleOfInvention |
METHOD FOR PRODUCING REGENERATED T CELL POPULATION VIA iPS CELLS |
| abstract |
The present invention provides a method for producing a regenerated T cell population via iPS cells, said regenerated T cell population maintaining the genetic diversity of a T cell population before reprogramming and having a tropism to an antigen. The aforesaid method comprises: (1) a step for contacting a T cell population with at least one tumor-associated antigen or a biological tissue containing at least one tumor-associated antigen, said biological tissue being optionally ground or melted, and concentrating a T cell population having a tropism to the tumor-associated antigen; (2) a step for reprogramming the concentrated T cell population into iPS cells and culturing while maintaining the genetic diversity of the concentrated T cell population; and (3) a step for producing a regenerated T cell population from the cultured iPS cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022220146-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022059780-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020251046-A1 |
| priorityDate |
2018-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |